<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cardiovascular benefits and risks of moderate alcohol consumption</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cardiovascular benefits and risks of moderate alcohol consumption</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cardiovascular benefits and risks of moderate alcohol consumption</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christine C Tangney, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert S Rosenson, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sara Swenson, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 16, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Excessive alcohol use can lead to a variety of adverse effects including liver disease, heart failure (HF), increased cancer risk, neurologic complications, and unintentional injuries. Balanced against these deleterious effects is the observation that, compared with abstinence or heavy drinking, moderate alcohol intake may have sex-specific health benefits, particularly in regard to cardiovascular disease (CVD) and diabetes.</p><p>The cardiovascular benefits and risks of alcohol consumption will be reviewed here. A general review of the risk and benefits of alcohol consumption is presented separately. (See  <a class="medical medical_review" href="/d/html/2781.html" rel="external">"Overview of the risks and benefits of alcohol consumption"</a>.)</p><p class="headingAnchor" id="H3134888429"><span class="h1">DEFINITIONS</span></p><p class="headingAnchor" id="H229661454"><span class="h2">Moderate drinking</span><span class="headingEndMark"> — </span>The 2020 to 2025 Dietary Guidelines for Americans define moderate drinking as having up to one drink per day for females and up to two drinks per day for males  (<a class="graphic graphic_table graphicRef114779" href="/d/graphic/114779.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. This definition refers to the amount of alcohol consumed on any single day and is not intended as an average over several days. The definition of the dose (grams of alcohol) which provides protection from all-cause mortality or specific cardiovascular outcomes has been challenged [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H2091959850"><span class="h2">Standard drink</span><span class="headingEndMark"> — </span>Definitions of a "standard drink" differ, both within and between countries  (<a class="graphic graphic_figure graphicRef56818" href="/d/graphic/56818.html" rel="external">figure 1</a>) [<a href="#rid3">3,4</a>]. The Global Burden of Disease Study defined a standard drink as 10 grams of pure ethyl alcohol consumed daily [<a href="#rid2">2</a>]. However, in the United States, a standard drink contains 14 grams (0.6 fluid ounces) of pure alcohol, and around the world the standard drink ranges from as few as 8 grams of alcohol to as many as 20 grams of alcohol [<a href="#rid3">3,5,6</a>]. (See  <a class="medical medical_review" href="/d/html/2781.html" rel="external">"Overview of the risks and benefits of alcohol consumption", section on 'Standard drink size'</a>.)</p><p class="headingAnchor" id="H4255530084"><span class="h2">Beverage type</span><span class="headingEndMark"> — </span>Available data do not clearly support a definitive conclusion regarding the differential benefits of various beverage types. However, it is generally accepted that the type of alcohol is not as important a factor as the amount of alcohol consumed and the pattern of intake [<a href="#rid7">7-9</a>].</p><p>However, the French paradox that coronary heart disease (CHD) mortality is lower in France than would be expected from the high national prevalence of smoking and saturated fat intake has been attributed to frequent red wine consumption [<a href="#rid10">10</a>]. Red wine contains phenolic and flavonoid substances that have antithrombotic and antioxidant properties [<a href="#rid11">11,12</a>]. Additionally, wine intake has been associated with improvements in heart rate variability [<a href="#rid13">13</a>], which could contribute to improved prognosis for CHD [<a href="#rid11">11,14</a>].</p><p>Data from clinical studies vary on whether the type of alcoholic beverage is a factor in the cardioprotective effect of alcohol, with some suggesting that all alcoholic beverages afford cardioprotective benefits [<a href="#rid15">15</a>], while others report that the cardioprotection is strongest for wine [<a href="#rid16">16,17</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>A dose-response relationship on risk of vascular events was seen for both wine and beer, but the relationship was stronger for wine. A J-shaped relationship was again observed between alcohol dose and total mortality [<a href="#rid16">16,17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One systematic review found that all beverage types are associated with lower rates of CHD [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 13 cohort studies, including 209,418 people, reported a strong and statistically significant benefit for moderate consumption of both beer and wine, although the effect was stronger for wine (32 versus 22 percent relative risk [RR] reduction) [<a href="#rid17">17</a>]. A dose-response relationship was seen for both wine and beer with vascular risk, but the relationship was stronger for wine. A J-shaped relationship was again observed for alcohol dose and total mortality.</p><p></p><p class="headingAnchor" id="H2003317192"><span class="h1">ADVICE TO PATIENTS REGARDING ALCOHOL USE</span><span class="headingEndMark"> — </span>Our approach to advising patients about the benefits of alcohol as part of a strategy to reduce cardiovascular disease (CVD) risk is as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Individuals who are not currently drinking, or those who have a personal preference to avoid alcohol, should not be advised to consume alcohol solely for the purpose of CVD risk reduction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who have an underlying medical condition that precludes alcohol use (eg, alcohol use disorder, liver disease, etc) should not be advised to consume alcohol.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who choose to drink moderate amounts of alcohol, such as those who drink alcohol less than one unit per day (or less than 15 g per day) [<a href="#rid19">19</a>] or less than 100 g per week [<a href="#rid20">20</a>] may experience benefits for their health.</p><p></p><p>Caution is necessary when promoting the beneficial effects of alcohol for cardiovascular risk reduction. The absolute benefits of alcohol consumption are unclear in the absence of randomized controlled trials. There is little agreement regarding the upper limit of alcohol consumption that correlates with cardiovascular benefit, nor are there good data about which group of individuals might benefit from different levels of alcohol at no additional risk. (See <a class="local">'Effect of alcohol on cardiovascular risk'</a> below.)</p><p>The potential cardiovascular benefit of moderate alcohol intake must be balanced against the effect of alcohol on other disorders, such as cirrhosis and cancer, and the total alcohol-attributable deaths [<a href="#rid21">21,22</a>]. The net risk-benefit balance associated with moderate alcohol consumption will vary in different age groups and populations. As an example, alcohol intake increases the risk for breast cancer in females [<a href="#rid21">21</a>]. For a young woman with a low risk for coronary disease, the increased risk related to alcohol intake and breast cancer might outweigh any potential cardiovascular benefits. (See  <a class="medical medical_review" href="/d/html/2781.html" rel="external">"Overview of the risks and benefits of alcohol consumption", section on 'Breast cancer'</a>.)</p><p class="headingAnchor" id="H2871867864"><span class="h1">PROPOSED MECHANISMS OF BENEFIT</span><span class="headingEndMark"> — </span>Factors responsible for the apparent cardiovascular benefits of light to moderate alcohol intake are <strong>uncertain</strong>. A meta-analysis evaluated 42 clinical studies with information about biochemical markers assessed before and after consumption of ethanol [<a href="#rid23">23</a>]. The following beneficial changes, which were noted with an experimental dose of 30 grams of ethanol per day, would be estimated to reduce the risk of coronary heart disease (CHD) by 25 percent:</p><p class="bulletIndent1"><span class="glyph">●</span>Serum apolipoprotein A-I increased by 8.8 mg/dL</p><p class="bulletIndent1"><span class="glyph">●</span>Plasma fibrinogen concentration decreased by 7.5 mg/dL</p><p class="bulletIndent1"><span class="glyph">●</span>Tissue-type plasminogen activator (tPA) concentration increased by 1.25 ng/mL</p><p class="bulletIndent1"><span class="glyph">●</span>Serum triglycerides increased by 5.7 mg/dL (potentially detrimental rather than beneficial)</p><p></p><p>For many decades, light to moderate alcohol intake was proposed as a way to increase serum high-density lipoprotein (HDL) cholesterol and thereby reduce cardiovascular risk. While an increase of serum HDL cholesterol by 4 mg/dL or (0.1 mmol/L) may occur following light to moderate alcohol intake, it should not be expected [<a href="#rid23">23</a>]. An updated meta-analysis found similar results, finding a dose response for increased HDL cholesterol levels and similar responses for the other markers listed above [<a href="#rid24">24,25</a>]. However, strategies directed at raising HDL cholesterol as a means of reducing cardiovascular events have failed in multiple clinical trials [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/d/html/4560.html" rel="external">"HDL cholesterol: Clinical aspects of abnormal values"</a>.)</p><p>However, the effects of alcohol on various HDL functional measures requires further exploration. In Mendelian randomization studies, self-reported alcohol intakes of Japanese adults were linearly related to increases in HDL particle numbers and decreases in low-density lipoprotein (LDL) particle numbers [<a href="#rid27">27</a>]. Still, others propose that the cardioprotective effects of alcohol may be related to the metabolite, acetate, and its interaction with the adipocyte free fatty acid receptor 2 to elicit an antilipolytic effect [<a href="#rid28">28</a>]. Changes in HDL cholesterol are markers of lower CHD risk but not a target of nonpharmacologic or pharmacologic therapy [<a href="#rid26">26</a>]. (See  <a class="medical medical_review" href="/d/html/1810.html" rel="external">"Pathogenesis of type 2 diabetes mellitus"</a>.)</p><p class="headingAnchor" id="H564448214"><span class="h2">Antioxidant effects</span><span class="headingEndMark"> — </span>Red wine and two of its antioxidants, but not other sources of alcohol, also prevent the activation of mononuclear cell nuclear factor kappa B, a redox-sensitive transcription factor that is involved in various processes that may contribute to atherosclerosis [<a href="#rid29">29</a>]. In another study, use of antioxidants <a class="drug drug_general" data-topicid="9317" href="/d/drug information/9317.html" rel="external">N-acetylcysteine</a> and resveratrol from wine inhibited macrophage reactive oxygen species production and facilitated cell migration through restoration of focal adhesion kinase activity [<a href="#rid30">30</a>].</p><p>Further study of the dynamic modeling of arterial lesions by dietary or other lifestyle behaviors is warranted. Endothelial progenitor cells are mobilized into circulation when vascular repair and neovascularization are needed. Red wine and a major constituent of red wine, resveratrol, slow endothelial progenitor cell senescence through a protein kinase B (Akt) dependent mechanism [<a href="#rid31">31</a>]. When 14 healthy volunteers consumed 250 mL of red wine for 21 consecutive days, apoptosis of endothelial progenitor cells was reduced and their migration and proliferation were significantly improved [<a href="#rid29">29</a>]. These findings may contribute to the mechanism of cardiovascular protection observed with regular, moderate consumption of red wine.</p><p class="headingAnchor" id="H3771799789"><span class="h2">Enhanced insulin sensitivity</span><span class="headingEndMark"> — </span>Consuming moderate amounts of alcohol has been shown to enhance insulin sensitivity and glucose utilization for the subsequent 12 to 24 hours [<a href="#rid32">32</a>]. Fasting and postprandial insulin concentrations are reduced with two drinks per day, and insulin sensitivity is also improved in randomized controlled trials [<a href="#rid33">33</a>]. The mechanism by which insulin sensitivity is enhanced by alcohol is not entirely known but may involve suppression of fatty acid release from adipose tissue and improved glucose metabolism [<a href="#rid28">28,34</a>]. A more detailed discussion of this subject is presented separately. (See  <a class="medical medical_review" href="/d/html/2781.html" rel="external">"Overview of the risks and benefits of alcohol consumption", section on 'Diabetes mellitus'</a>.)</p><p class="headingAnchor" id="H1825389987"><span class="h2">Antithrombotic effects</span><span class="headingEndMark"> — </span>Alcohol has antithrombotic activities that may contribute to the observed reduction in CHD. These include modification of platelet function and of other components of the clotting system and fibrinolysis [<a href="#rid11">11,12</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Platelet aggregation is inhibited by the same quantities of alcohol that reduce CHD risk [<a href="#rid35">35</a>]; this effect may persist for six hours after a single alcohol drink, even when the blood alcohol level has returned to baseline [<a href="#rid36">36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fibrinolysis also may be induced by moderate alcohol intake (three to seven drinks per week) and may contribute to the cardiovascular benefit. Reduced levels of plasminogen activator inhibitor (PAI) activity, fibrinogen, plasma viscosity, von Willebrand factor, factor VII, and increased concentrations of tissue-type plasminogen activator (tPA) have been described [<a href="#rid37">37,38</a>].</p><p></p><p>By contrast, a higher intake of alcohol (7 to 21 drinks per week) is associated with impaired fibrinolytic potential, manifested by higher levels of PAI antigen-1 and tPA antigen [<a href="#rid37">37</a>]. </p><p class="headingAnchor" id="H2074088699"><span class="h2">Antiinflammatory effects</span><span class="headingEndMark"> — </span>There appears to be an inverse relationship between levels of inflammatory markers and mild to moderate alcohol intake.</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with moderate alcohol consumption have lower concentrations of C-reactive protein (CRP) than those who consume occasional or no alcohol [<a href="#rid39">39</a>]. In the PRINCE study, which correlated self-reported alcohol intake with CRP levels in 2833 subjects (41 percent with a history of cardiovascular disease [CVD]), there was a progressive decline in CRP levels with increasing alcohol intake, from 2.6 mg/L for less than one drink per month to 1.6 mg/L for five to seven drinks per week.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study of alcohol intake and inflammatory markers in a biracial cohort of 2574 older people (aged 70 to 79 years) identified a J-shaped relationship between alcohol intake and both interleukin (IL) 6 and CRP levels [<a href="#rid40">40</a>]. Compared with people who drank one to seven drinks per week, people who never drank or who drank eight or more drinks per week were more likely to have high levels of IL-6 and CRP. However, in a subsequent study from the same population, the benefit of light to moderate alcohol intake on cardiac events and mortality persisted even after adjustment for levels of CRP and IL-6, leading to questions of the role of antiinflammatory properties as a mechanism of cardioprotection [<a href="#rid41">41</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h1">EFFECT OF ALCOHOL ON CARDIOVASCULAR RISK</span></p><p class="headingAnchor" id="H903182590"><span class="h2">Overview</span><span class="headingEndMark"> — </span>No long-term randomized trials of alcohol consumption have been performed. The available evidence is from observational studies (including meta-analyses of numerous studies) that typically compare the characteristics of alcohol users with nonusers. As such, the apparent effect of alcohol is subject to confounding. As one example, moderate alcohol use is more common among those of higher socioeconomic status, thereby introducing the likelihood of confounding by factors associated with higher socioeconomic status [<a href="#rid42">42,43</a>].</p><p>Evidence from trend analyses by the National Health and Examination Survey (NHANES) over a 15-year period (1999 to 2014) linked to the United States mortality registry in 2015 suggest that alcohol use has increased and that use above the recommended limits by the Dietary Guidelines for Americans was associated with enhanced all-cause and cause-specific mortality risk, ranging from 39 to 126 percent [<a href="#rid44">44</a>].</p><p>Several prospective cohort studies suggest that light to moderate alcohol consumption decreases the risk of coronary heart disease (CHD) by 40 to 70 percent, compared with drinking no alcohol or with heavy alcohol intake [<a href="#rid7">7</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>A 2011 meta-analysis of 84 observational studies found that, relative to nondrinkers, alcohol drinkers had a relative risk (RR) of 0.75 (95% CI 0.70-0.80) for cardiovascular disease (CVD) mortality, 0.75 (95% CI 0.68-0.81) for CHD mortality, and 0.71 (95% CI 0.66-0.77) for incident CHD [<a href="#rid45">45</a>]. This protective effect has been found in multiple groups, including individuals without CHD at baseline [<a href="#rid20">20</a>], those with risk factors for CHD [<a href="#rid22">22,46</a>], and adults over age 65 [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a pooled analysis of nearly 600,000 patients from three major cohorts in which the comparisons are made for current drinkers, the risk of myocardial infarction (MI) was lowest in the patients whose consumption was greater than 0 but less than 100 grams per week  (<a class="graphic graphic_figure graphicRef119228" href="/d/graphic/119228.html" rel="external">figure 2</a>) [<a href="#rid20">20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A population-based cohort study from the United Kingdom followed close to two million adults ≥30 years old who were free from CVD [<a href="#rid48">48</a>]. At a median follow-up of six years, 5.9 percent of these individuals had received a cardiovascular diagnosis. Non-drinking compared with moderate drinking was associated with an increased risk of multiple CVD outcomes, including unstable angina, MI, CHD death, heart failure (HF), ischemic stroke, and peripheral arterial disease, whereas heavy drinking was generally associated with worse cardiovascular outcomes.</p><p></p><p>However, in a cross-sectional study of over 2000 drinkers in Russia, levels of high-sensitivity cardiac troponin T, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and high-sensitivity C-reactive protein (CRP) were greater among those receiving treatment for alcohol problems than in the general population, and greater alcohol intake was associated with higher NT-proBNP and CRP levels across all drinkers, without a protective effect among light to moderate drinkers [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Cardiovascular mortality</span><span class="headingEndMark"> — </span>Many studies have found that moderate alcohol consumption is associated with a specific reduction in cardiovascular mortality [<a href="#rid45">45,50,51</a>]. However, other results show no benefit on all-cause mortality [<a href="#rid2">2,20,52</a>]. Additionally, heavy alcohol consumption (six or more drinks per day) or binge drinking increases the risk for many medical conditions, including sudden cardiac death [<a href="#rid2">2,53</a>]. (See  <a class="medical medical_review" href="/d/html/963.html" rel="external">"Overview of sudden cardiac arrest and sudden cardiac death"</a>.)</p><p class="headingAnchor" id="H443359953"><span class="h3">Patients without known CVD</span><span class="headingEndMark"> — </span>Findings from representative studies of patients without known CVD include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Data collected over nine iterations of the National Health Interview Study (NHIS), a representative United States sample, including 10,000 cardiovascular deaths, reveal an inverse association with cardiovascular mortality and light and moderate alcohol consumption [<a href="#rid50">50</a>]. Compared with lifetime abstainers, the RR of CVD was 0.69 and 0.62 for light and moderate drinkers, respectively. Similarly, after 13 waves of NHIS (including death index records in 2011), compared with lifetime abstainers, the RR of CVD was 0.74 (95% CI 0.69-0.80) and 0.71 (95% CI 0.64-0.78) for light and moderate drinkers, respectively  (<a class="graphic graphic_figure graphicRef119228" href="/d/graphic/119228.html" rel="external">figure 2</a>) [<a href="#rid46">46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a combined analysis of three large-scale data sources (Emerging Risk Factor Collaboration, European Prospective Investigation into Cancer and Nutrition [EPIC] – Cardiovascular Disease, and United Kingdom Biobank) of 19 high-income countries and across 83 prospective studies, 599,912 current drinkers were followed for a minimum of one year and a median of 7.5 years [<a href="#rid20">20</a>]. The main analyses focused on current drinkers whose baseline alcohol intakes were defined in grams consumed per week. There was a J-shaped association for CVD outcomes. After adjustment for age, sex, smoking, and history of diabetes, the amount of alcohol consumed had positive associations with all disease subtypes except for MI, and associations were stronger for fatal versus nonfatal events. For CVD subtypes other than MI, there was no definitive threshold below which lower alcohol intakes ceased being associated with lower risk of disease. For MI, the association was inverse and stronger for non-fatal than fatal associations  (<a class="graphic graphic_figure graphicRef119243" href="/d/graphic/119243.html" rel="external">figure 3</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>What if middle-aged adults initiate moderate alcohol consumption in an attempt to lower CVD risk? Initiation of moderate drinking in adults aged 45 to 64 years was associated with a 40 percent decrease in risk of cardiovascular events (odds ratio [OR] 0.62, 95% CI 0.41-0.94) over four years in a cohort of prior nondrinkers participating in the Atherosclerosis Risk in Communities (ARIC) survey [<a href="#rid54">54</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>By contrast, the cardioprotection of light to moderate alcohol intake is not universally seen. In a meta-analysis using 694 data sources of individual and population-level alcohol consumption from 592 prospective and retrospective studies, which included 28 million individuals aged 15 to 49 years, 12.2 percent of male deaths and 3.8 percent of female deaths were attributed to alcohol use [<a href="#rid2">2</a>]. The protective effects of alcohol consumption on CVD were complex in populations aged 50 years and older; these associations were influenced by sex, age, and socio-demographic status. For men residing in countries with high or low socio-demographic index (SDI), light to moderate alcohol consumption had a protective effect on ischemic heart disease. For females in high SDI regions, there<em> </em>were protective effects of alcohol on diabetes beyond 60 years of age<em>.</em> In a sensitivity analysis that explored the weighted influence for various health outcomes, the only protective effect of alcohol was observed in populations where diabetes and ischemic heart disease comprised more than 60 percent of total deaths. In at least two other pooled analyses, the cardioprotective influence of light to moderate alcohol consumption was not observed [<a href="#rid52">52,55</a>].</p><p></p><p class="headingAnchor" id="H20218140"><span class="h3">Patients with known CVD</span><span class="headingEndMark"> — </span>Moderate alcohol intake also appears to be beneficial in patients with known CVD. A 2010 meta-analysis of eight prospective studies, including 16,351 patients with a history of CVD, found a J-shaped curve between alcohol consumption and cardiovascular mortality, with a maximal protection (22 percent decreased risk) for consumption of 26 g per day of alcohol, equivalent to slightly less than two glasses of alcohol daily [<a href="#rid56">56</a>]. In a subsequent study of 1818 men from the Health Professionals Follow-up Study with prior MI, a U-shaped relationship between alcohol consumption and mortality (both all-cause and cardiovascular) was seen, with the greatest benefit for alcohol consumption between 10 and 30 grams per day, compared with abstinence (for all-cause mortality, hazard ratio [HR] 0.66, 95% CI 0.51-0.86; for cardiovascular mortality, HR 0.58, 95% CI 0.39-0.84). [<a href="#rid57">57</a>].</p><p>However, binge drinking in patients with a history of MI is associated with increased mortality [<a href="#rid58">58</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Coronary heart disease</span><span class="headingEndMark"> — </span>Similar to the benefit on total CVD mortality, moderate alcohol consumption is associated with a reduced risk of CHD in all adults [<a href="#rid15">15,59-61</a>].</p><p>Binge drinking, however, increases the risk for CHD [<a href="#rid62">62,63</a>]. As one example, in a pooled meta-analysis of case-control studies, the RR for fatal and nonfatal MI was 1.45 (95% CI 1.24-1.70) comparing those who reported irregular heavy drinking (≥5 drinks per occasion or intoxication at least monthly) with those who did not [<a href="#rid62">62</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Hypertension</span><span class="headingEndMark"> — </span>Multiple studies have shown an association between excess alcohol intake and the development of hypertension [<a href="#rid64">64-66</a>]. However, light to moderate alcohol consumption may be beneficial in reducing the risk of hypertension.</p><p>In a review of 32 trials of alcohol consumption in healthy persons, alcohol had a biphasic effect on blood pressure in the hours after consumption [<a href="#rid67">67</a>]. Although both medium- (14 to 28 grams) and high-dose alcohol (greater than 30 grams) decreased blood pressure within six hours of consumption, high-dose alcohol produced an increase in blood pressure after 12 hours.</p><p>In a meta-analysis of 36 trials, a decrease in alcohol intake reduced blood pressure in people who drank more than two drinks per day; however, a reduction was not seen in those consuming two or fewer drinks per day [<a href="#rid68">68</a>]. In patients who consumed six or more drinks per day, a 50 percent decrease in alcohol intake resulted in a 5.5 mmHg (95% CI 4.3-6.7) reduction in systolic blood pressure and a 4 mmHg (95% CI 3.2-4.7) reduction in diastolic blood pressure. (See  <a class="medical medical_review" href="/d/html/3818.html" rel="external">"Definition, risk factors, and evaluation of resistant hypertension"</a>.)</p><p>On the other hand, moderate alcohol intake appears to have a cardioprotective effect, even in patients with preexisting hypertension [<a href="#rid69">69,70</a>]. A 2014 meta-analysis of nine cohort studies including over 390,000 patients with hypertension found that, compared with abstainers or occasional drinkers, those who consumed 8 to 10 grams of alcohol per day had a decreased risk for all-cause mortality (RR 0.82, 95% CI 0.76-0.88) [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Heart failure</span><span class="headingEndMark"> — </span>Chronic consumption of large amounts of alcohol may lead to alcohol-induced cardiomyopathy. This condition is discussed separately. (See  <a class="medical medical_review" href="/d/html/3467.html" rel="external">"Alcohol-induced cardiomyopathy"</a>.)</p><p>By comparison, light to moderate alcohol intake may protect against the development of HF [<a href="#rid71">71,72</a>]. Among 7686 subjects initially free of HF or coronary disease prospectively followed in the Framingham Heart Study, the risk of HF in men was significantly lower at all levels of alcohol consumption, whereas among females, the consumption of one to seven drinks per week was also associated with a lower risk of HF [<a href="#rid73">73</a>].</p><p>A related issue is the effect of light to moderate alcohol intake in patients with left ventricular (LV) dysfunction. The SOLVD study evaluated this issue in an analysis of 6797 patients with an ejection fraction of 35 percent or less [<a href="#rid74">74</a>]. When compared with nondrinkers, light to moderate drinkers (1 to 14 drinks per week) with ischemic LV dysfunction had a lower all-cause mortality (7.2 versus 9.4 deaths/100 person-years), particularly death from MI. Alcohol had no significant effect on mortality in patients with a nonischemic cardiomyopathy.</p><p class="headingAnchor" id="H10"><span class="h2">In patients with diabetes mellitus</span><span class="headingEndMark"> — </span>Light to moderate alcohol consumption appears to protect against development of CHD and the risk of coronary death in adults with diabetes [<a href="#rid75">75-77</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In the Health Professionals Follow-up Study of 2419 men with type 2 diabetes over the age of 30, moderate alcohol intake was associated with a lower risk for CHD [<a href="#rid77">77</a>]. Alcohol also protects against the risk of CHD death in patients with diabetes. Among 2790 men with diabetes in the Physicians' Health Study who were free of MI, cancer, or liver disease at baseline, those men with diabetes who consumed alcohol on a weekly or daily basis had a significantly lower risk of death from CHD compared with those who rarely or never consumed alcohol (adjusted RR 0.67 and 0.42) [<a href="#rid75">75</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among 5103 females in the Nurses' Health Study with a diagnosis of diabetes at ≥30 years of age who were free of CHD, stroke, or cancer at baseline, the adjusted RR for nonfatal or fatal CHD for diabetic females reporting a daily intake of 0.1 to 4.9 grams of alcohol (&lt;0.5 drinks) or ≥5.0 grams (≥0.5 drinks) was 0.72 and 0.45, respectively, compared with abstainers [<a href="#rid76">76</a>]. (See  <a class="medical medical_review" href="/d/html/1542.html" rel="external">"Prevalence of and risk factors for coronary heart disease in patients with diabetes mellitus"</a>.)</p><p></p><p>In addition, moderate alcohol consumption may lower the risk of developing type 2 diabetes, as reported in a meta-analyses of 15 prospective cohort studies [<a href="#rid78">78</a>]. (See  <a class="medical medical_review" href="/d/html/2781.html" rel="external">"Overview of the risks and benefits of alcohol consumption", section on 'Diabetes mellitus'</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Stroke risk</span><span class="headingEndMark"> — </span>Different studies have reported disparate outcomes regarding the impact of light to moderate alcohol intake on stroke risk.</p><p class="bulletIndent1"><span class="glyph">●</span>Moderate alcohol intake (up to two glasses per day) has been associated with a decreased risk of ischemic stroke in most studies [<a href="#rid45">45,79-82</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a combined analysis of three large-scale data sources (Emerging Risk Factor Collaboration, European Prospective Investigation into Cancer and Nutrition [EPIC] – Cardiovascular Disease, and United Kingdom Biobank) of 19 high-income countries and across 83 prospective studies, 599,912 current drinkers were followed for a minimum of one year and a median of 7.5 years  (<a class="graphic graphic_figure graphicRef119239" href="/d/graphic/119239.html" rel="external">figure 4</a>) [<a href="#rid20">20</a>]. The amount of alcohol had a positive, nearly linear relationship with stroke (HR 1.14, 95% CI 1.10-1.17), both ischemic and hemorrhagic.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a cohort study of 38,156 male health professionals published subsequent to this meta-analysis, light alcohol consumption (&lt;10 g/day) had no effect on the risk of ischemic stroke (RR 0.99, 95% CI 0.72-1.37) [<a href="#rid80">80</a>]. Consumption of more than two drinks daily (&gt;29.9 g per day) appeared to be associated with an increased risk of ischemic stroke (RR 1.42, 95% CI 0.97-2.09). Data collected over 26 years (&gt;1,695,000 person-years) from the Nurses' Health Study found that, compared with abstainers, the risk of stroke was decreased in females who drank less than 15 g/day of alcohol (RR 0.83, 95% CI 0.75-0.92 for &lt;5 g per day and RR 0.79, 95% CI 0.70-0.90 for 5.0 to 14.9 g per day) [<a href="#rid82">82</a>]. There was no difference between the incidence of ischemic or hemorrhagic stroke.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Binge drinking (≥6 drinks in one session for males, or ≥4 drinks for females) was associated with increased risk for all strokes (HR 1.85) and for ischemic strokes (HR 1.99) [<a href="#rid83">83</a>].</p><p></p><p class="headingAnchor" id="H12"><span class="h2">Peripheral artery disease</span><span class="headingEndMark"> — </span>Alcohol appears to reduce the risk of peripheral artery disease (PAD) among apparently healthy people. Moderate alcohol intake (one to two drinks per day in males and 0.5 to 1.0 drinks per day in females) also reduces the risk of intermittent claudication [<a href="#rid84">84</a>]. It is difficult to account for the influences of dietary pattern and alcohol consumption on disease outcomes, although the PREDMED study examined the risk of developing PAD in their trial participants; nearly 50 percent had type 2 diabetes. Moderate alcohol consumption, non-smoking, physical activity, and following a Mediterranean diet pattern were inversely associated with incident PAD [<a href="#rid85">85</a>].</p><p>The effects of alcohol on risk for abdominal aortic aneurysm are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Food and alcohol consumption'</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Atrial fibrillation</span><span class="headingEndMark"> — </span>Both heavy binge drinking and heavy chronic alcohol use have been reported to increase the incidence of atrial fibrillation (AF), while chronic moderate alcohol use does not appear to increase the incidence of AF. Evidence suggests there is <strong>no</strong> benefit from light to moderate alcohol intakes with respect to incident AF [<a href="#rid86">86</a>]. Even ablation treatment for AF is less successful amongst moderate and heavy drinkers [<a href="#rid87">87</a>]. (See  <a class="medical medical_review" href="/d/html/1004.html" rel="external">"Epidemiology, risk factors, and prevention of atrial fibrillation", section on 'Alcohol'</a>.)</p><p class="headingAnchor" id="H2032834202"><span class="h2">Advice from professional societies</span><span class="headingEndMark"> — </span>There is uncertainty as to whether the available data support encouraging middle-aged adults, with or without CHD, who do not drink or who drink only occasionally to take up regular drinking [<a href="#rid3">3,7,88-91</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In 2001, an American Heart Association (AHA) Science Advisory reached the following conclusion [<a href="#rid92">92</a>]: "Moderate intake of alcoholic beverages (one to two drinks per day) is associated with a reduced risk of CHD in populations… Despite the biologic plausibility and observational data in this regard, it should be kept in mind that these are insufficient to prove causality… Without a large-scale, randomized, clinical end point trial of wine intake, there is little current justification to recommend alcohol (or wine specifically) as a cardioprotective strategy."</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The National Institute on Alcohol Abuse and Alcoholism (NIAAA) indicates that "individuals who are not currently drinking should not be encouraged to drink solely for health reasons, because the basis for health improvements has not yet been established as deriving from alcohol itself" [<a href="#rid93">93</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A 2016 report from the Department of Health in the United Kingdom states that "people who do not drink any alcohol at all should not be recommended to start drinking in the interests of their health" [<a href="#rid94">94</a>].</p><p></p><p class="headingAnchor" id="H4049853353"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/123018.html" rel="external">"Society guideline links: Alcohol consumption"</a>.)</p><p class="headingAnchor" id="H22"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/2725.html" rel="external">"Patient education: Risks and benefits of alcohol (Beyond the Basics)"</a>)</p><p></p><p>The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the National Institutes of Health (NIH) maintains an active website for the general public (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.niaaa.nih.gov%2Falcohols-effects-health&amp;token=lblfowwGB6QwC91WNuiIf6Hr8v7h1w6tKEcXM3AT4U2WiwO%2BZJnZKQcuJ90risyMR%2Bg7DdeptY6D5vbsT3ZBSg%3D%3D&amp;TOPIC_ID=2784" target="_blank">www.niaaa.nih.gov/alcohol-health</a>). Patient information specific to the interaction of alcohol intake and the effect on the body is available within this site (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.niaaa.nih.gov%2Falcohols-effects-health%2Falcohols-effects-body&amp;token=lblfowwGB6QwC91WNuiIf6Hr8v7h1w6tKEcXM3AT4U2WiwO%2BZJnZKQcuJ90risyMm3inxScqtKszqD6yiZeGJw%3D%3D&amp;TOPIC_ID=2784" target="_blank">www.niaaa.nih.gov/alcohol-health/alcohols-effects-body</a>).</p><p class="headingAnchor" id="H23"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>The 2020 to 2025 Dietary Guidelines for Americans define moderate drinking as having up to one drink per day for females and up to two drinks per day for males. Definitions of a "standard drink" differ, both within and between countries, with a standard drink containing from as few as 8 grams of alcohol to as many as 20 grams of alcohol. (See <a class="local">'Definitions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moderate alcohol consumption most likely reduces the risk of myocardial infarction (MI) through its effects on insulin sensitivity, thrombotic activity, and inflammation. (See <a class="local">'Proposed mechanisms of benefit'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It is uncertain whether wine is more cardioprotective than other types of alcohol; however, it is likely that the type of alcohol is not as important as the amount of alcohol consumed and the pattern of intake. (See <a class="local">'Beverage type'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No long-term randomized trials of alcohol consumption have been performed. Most studies have found that light to moderate alcohol consumption is associated with a specific reduction in cardiovascular mortality, with several prospective cohort studies suggesting that light to moderate alcohol consumption decreases the risk of coronary heart disease (CHD) compared with drinking no alcohol or with heavy alcohol intake. However, other data have challenged this potential benefit on CHD risk and CHD mortality, and no level of drinking has shown to be beneficial for other cardiovascular disease (CVD) risks (eg, stroke, hypertension, heart failure [HF], etc). (See <a class="local">'Effect of alcohol on cardiovascular risk'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Our approach to advising patients about the benefits of alcohol as part of a strategy to reduce CVD risk is as follows (see <a class="local">'Advice to patients regarding alcohol use'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Individuals who are not currently drinking, or those who have a personal preference to avoid alcohol, should not be advised to consume alcohol solely for the purpose of CVD risk reduction.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients who have an underlying medical condition that precludes alcohol use (eg, alcohol use disorder, liver disease, etc) should not be advised to consume alcohol and seek counseling, if needed, to abstain from alcohol.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients who choose to drink moderate amounts of alcohol, such as those who drink alcohol less than one unit per day (or less than 15 g per day) or less than 100 g per week, may experience benefits for their health.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf.</li><li><a class="nounderline abstract_t">GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2018; 392:1015.</a></li><li><a class="nounderline abstract_t">Kloner RA, Rezkalla SH. To drink or not to drink? That is the question. Circulation 2007; 116:1306.</a></li><li><a class="nounderline abstract_t">Kerr WC, Greenfield TK, Tujague J, Brown SE. A drink is a drink? Variation in the amount of alcohol contained in beer, wine and spirits drinks in a US methodological sample. Alcohol Clin Exp Res 2005; 29:2015.</a></li><li class="breakAll">https://www.responsibledrinking.eu/new-page/ (Accessed on October 08, 2018).</li><li class="breakAll">https://cancer-code-europe.iarc.fr/index.php/en/ecac-12-ways/alcohol-recommendation/27-standard-drink (Accessed on October 08, 2018).</li><li><a class="nounderline abstract_t">O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol 2007; 50:1009.</a></li><li><a class="nounderline abstract_t">Ellison RC. Importance of pattern of alcohol consumption. Circulation 2005; 112:3818.</a></li><li><a class="nounderline abstract_t">Leong DP, Smyth A, Teo KK, et al. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study. Circulation 2014; 130:390.</a></li><li><a class="nounderline abstract_t">Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339:1523.</a></li><li><a class="nounderline abstract_t">Lippi G, Franchini M, Favaloro EJ, Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". Semin Thromb Hemost 2010; 36:59.</a></li><li><a class="nounderline abstract_t">Haseeb S, Alexander B, Baranchuk A. Wine and Cardiovascular Health: A Comprehensive Review. Circulation 2017; 136:1434.</a></li><li><a class="nounderline abstract_t">Janszky I, Ericson M, Blom M, et al. Wine drinking is associated with increased heart rate variability in women with coronary heart disease. Heart 2005; 91:314.</a></li><li><a class="nounderline abstract_t">Abuissa H, O'Keefe JH Jr, Harris W, Lavie CJ. Autonomic function, omega-3, and cardiovascular risk. Chest 2005; 127:1088.</a></li><li><a class="nounderline abstract_t">Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003; 348:109.</a></li><li><a class="nounderline abstract_t">Grønbaek M, Deis A, Sørensen TI, et al. Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 1995; 310:1165.</a></li><li><a class="nounderline abstract_t">Di Castelnuovo A, Rotondo S, Iacoviello L, et al. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002; 105:2836.</a></li><li><a class="nounderline abstract_t">Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ 1996; 312:731.</a></li><li><a class="nounderline abstract_t">Djoussé L, Lee IM, Buring JE, Gaziano JM. Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms. Circulation 2009; 120:237.</a></li><li><a class="nounderline abstract_t">Wood AM, Kaptoge S, Butterworth AS, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 2018; 391:1513.</a></li><li><a class="nounderline abstract_t">Zhang SM, Lee IM, Manson JE, et al. Alcohol consumption and breast cancer risk in the Women's Health Study. Am J Epidemiol 2007; 165:667.</a></li><li><a class="nounderline abstract_t">Mostofsky E, Mukamal KJ, Giovannucci EL, et al. Key Findings on Alcohol Consumption and a Variety of Health Outcomes From the Nurses' Health Study. Am J Public Health 2016; 106:1586.</a></li><li><a class="nounderline abstract_t">Rimm EB, Williams P, Fosher K, et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319:1523.</a></li><li><a class="nounderline abstract_t">Brien SE, Ronksley PE, Turner BJ, et al. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ 2011; 342:d636.</a></li><li><a class="nounderline abstract_t">Vu KN, Ballantyne CM, Hoogeveen RC, et al. Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study. PLoS One 2016; 11:e0148765.</a></li><li><a class="nounderline abstract_t">Rosenson RS. The High-Density Lipoprotein Puzzle: Why Classic Epidemiology, Genetic Epidemiology, and Clinical Trials Conflict? Arterioscler Thromb Vasc Biol 2016; 36:777.</a></li><li><a class="nounderline abstract_t">Tabara Y, Ueshima H, Takashima N, et al. Mendelian randomization analysis in three Japanese populations supports a causal role of alcohol consumption in lowering low-density lipid cholesterol levels and particle numbers. Atherosclerosis 2016; 254:242.</a></li><li><a class="nounderline abstract_t">Pownall HJ, Gotto AM Jr. New Insights into the High-Density Lipoprotein Dilemma. Trends Endocrinol Metab 2016; 27:44.</a></li><li><a class="nounderline abstract_t">Hamed S, Alshiek J, Aharon A, et al. Red wine consumption improves in vitro migration of endothelial progenitor cells in young, healthy individuals. Am J Clin Nutr 2010; 92:161.</a></li><li><a class="nounderline abstract_t">Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 2009; 119:136.</a></li><li><a class="nounderline abstract_t">Xia L, Wang XX, Hu XS, et al. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol 2008; 155:387.</a></li><li><a class="nounderline abstract_t">Greenfield JR, Samaras K, Hayward CS, et al. Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab 2005; 90:661.</a></li><li><a class="nounderline abstract_t">Mukamal KJ, Mackey RH, Kuller LH, et al. Alcohol consumption and lipoprotein subclasses in older adults. J Clin Endocrinol Metab 2007; 92:2559.</a></li><li><a class="nounderline abstract_t">Avogaro A, Watanabe RM, Gottardo L, et al. Glucose tolerance during moderate alcohol intake: insights on insulin action from glucose/lactate dynamics. J Clin Endocrinol Metab 2002; 87:1233.</a></li><li><a class="nounderline abstract_t">Wannamethee SG, Lowe GD, Shaper G, et al. The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men. Thromb Haemost 2003; 90:1080.</a></li><li><a class="nounderline abstract_t">Lacoste L, Hung J, Lam JY. Acute and delayed antithrombotic effects of alcohol in humans. Am J Cardiol 2001; 87:82.</a></li><li><a class="nounderline abstract_t">Mukamal KJ, Jadhav PP, D'Agostino RB, et al. Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation 2001; 104:1367.</a></li><li><a class="nounderline abstract_t">van Golde PM, Hart HCh, Kraaijenhagen RJ, et al. Regular alcohol intake and fibrinolysis. Neth J Med 2002; 60:285.</a></li><li><a class="nounderline abstract_t">Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003; 107:443.</a></li><li><a class="nounderline abstract_t">Volpato S, Pahor M, Ferrucci L, et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 2004; 109:607.</a></li><li><a class="nounderline abstract_t">Maraldi C, Volpato S, Kritchevsky SB, et al. Impact of inflammation on the relationship among alcohol consumption, mortality, and cardiac events: the health, aging, and body composition study. Arch Intern Med 2006; 166:1490.</a></li><li><a class="nounderline abstract_t">Fillmore KM, Golding JM, Graves KL, et al. Alcohol consumption and mortality. I. Characteristics of drinking groups. Addiction 1998; 93:183.</a></li><li><a class="nounderline abstract_t">Naimi TS, Brown DW, Brewer RD, et al. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med 2005; 28:369.</a></li><li><a class="nounderline abstract_t">Ricci C, Schutte AE, Schutte R, et al. Trends in alcohol consumption in relation to cause-specific and all-cause mortality in the United States: a report from the NHANES linked to the US mortality registry. Am J Clin Nutr 2020; 111:580.</a></li><li><a class="nounderline abstract_t">Ronksley PE, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011; 342:d671.</a></li><li><a class="nounderline abstract_t">Xi B, Veeranki SP, Zhao M, et al. Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults. J Am Coll Cardiol 2017; 70:913.</a></li><li><a class="nounderline abstract_t">Mukamal KJ, Chung H, Jenny NS, et al. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J Am Geriatr Soc 2006; 54:30.</a></li><li><a class="nounderline abstract_t">Bell S, Daskalopoulou M, Rapsomaniki E, et al. Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ 2017; 356:j909.</a></li><li><a class="nounderline abstract_t">Iakunchykova O, Averina M, Kudryavtsev AV, et al. Evidence for a Direct Harmful Effect of Alcohol on Myocardial Health: A Large Cross-Sectional Study of Consumption Patterns and Cardiovascular Disease Risk Biomarkers From Northwest Russia, 2015 to 2017. J Am Heart Assoc 2020; 9:e014491.</a></li><li><a class="nounderline abstract_t">Mukamal KJ, Chen CM, Rao SR, Breslow RA. Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. J Am Coll Cardiol 2010; 55:1328.</a></li><li><a class="nounderline abstract_t">Dai J, Mukamal KJ, Krasnow RE, et al. Higher usual alcohol consumption was associated with a lower 41-y mortality risk from coronary artery disease in men independent of genetic and common environmental factors: the prospective NHLBI Twin Study. Am J Clin Nutr 2015; 102:31.</a></li><li><a class="nounderline abstract_t">Stockwell T, Zhao J, Panwar S, et al. Do "Moderate" Drinkers Have Reduced Mortality Risk? A Systematic Review and Meta-Analysis of Alcohol Consumption and All-Cause Mortality. J Stud Alcohol Drugs 2016; 77:185.</a></li><li><a class="nounderline abstract_t">Wannamethee G, Shaper AG. Alcohol and sudden cardiac death. Br Heart J 1992; 68:443.</a></li><li><a class="nounderline abstract_t">King DE, Mainous AG 3rd, Geesey ME. Adopting moderate alcohol consumption in middle age: subsequent cardiovascular events. Am J Med 2008; 121:201.</a></li><li><a class="nounderline abstract_t">Knott CS, Coombs N, Stamatakis E, Biddulph JP. All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts. BMJ 2015; 350:h384.</a></li><li><a class="nounderline abstract_t">Costanzo S, Di Castelnuovo A, Donati MB, et al. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol 2010; 55:1339.</a></li><li><a class="nounderline abstract_t">Pai JK, Mukamal KJ, Rimm EB. Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study. Eur Heart J 2012; 33:1598.</a></li><li><a class="nounderline abstract_t">Mukamal KJ, Maclure M, Muller JE, Mittleman MA. Binge drinking and mortality after acute myocardial infarction. Circulation 2005; 112:3839.</a></li><li><a class="nounderline abstract_t">Hvidtfeldt UA, Tolstrup JS, Jakobsen MU, et al. Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation 2010; 121:1589.</a></li><li><a class="nounderline abstract_t">Gémes K, Janszky I, Laugsand LE, et al. Alcohol consumption is associated with a lower incidence of acute myocardial infarction: results from a large prospective population-based study in Norway. J Intern Med 2016; 279:365.</a></li><li><a class="nounderline abstract_t">Arriola L, Martinez-Camblor P, Larrañaga N, et al. Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study. Heart 2010; 96:124.</a></li><li><a class="nounderline abstract_t">Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol 2010; 171:633.</a></li><li><a class="nounderline abstract_t">Ruidavets JB, Ducimetière P, Evans A, et al. Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). BMJ 2010; 341:c6077.</a></li><li><a class="nounderline abstract_t">Stranges S, Wu T, Dorn JM, et al. Relationship of alcohol drinking pattern to risk of hypertension: a population-based study. Hypertension 2004; 44:813.</a></li><li><a class="nounderline abstract_t">Beilin LJ, Puddey IB. Alcohol and hypertension: an update. Hypertension 2006; 47:1035.</a></li><li><a class="nounderline abstract_t">Lawlor DA, Nordestgaard BG, Benn M, et al. Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population Study. Eur Heart J 2013; 34:2519.</a></li><li><a class="nounderline abstract_t">Tasnim S, Tang C, Musini VM, Wright JM. Effect of alcohol on blood pressure. Cochrane Database Syst Rev 2020; 7:CD012787.</a></li><li><a class="nounderline abstract_t">Roerecke M, Kaczorowski J, Tobe SW, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health 2017; 2:e108.</a></li><li><a class="nounderline abstract_t">Beulens JW, Rimm EB, Ascherio A, et al. Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med 2007; 146:10.</a></li><li><a class="nounderline abstract_t">Huang C, Zhan J, Liu YJ, et al. Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies. Mayo Clin Proc 2014; 89:1201.</a></li><li><a class="nounderline abstract_t">Bryson CL, Mukamal KJ, Mittleman MA, et al. The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. J Am Coll Cardiol 2006; 48:305.</a></li><li><a class="nounderline abstract_t">Djoussé L, Gaziano JM. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation 2007; 115:34.</a></li><li><a class="nounderline abstract_t">Walsh CR, Larson MG, Evans JC, et al. Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2002; 136:181.</a></li><li><a class="nounderline abstract_t">Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000; 35:1753.</a></li><li><a class="nounderline abstract_t">Ajani UA, Gaziano JM, Lotufo PA, et al. Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 2000; 102:500.</a></li><li><a class="nounderline abstract_t">Solomon CG, Hu FB, Stampfer MJ, et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 2000; 102:494.</a></li><li><a class="nounderline abstract_t">Tanasescu M, Hu FB, Willett WC, et al. Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus. J Am Coll Cardiol 2001; 38:1836.</a></li><li><a class="nounderline abstract_t">Koppes LL, Dekker JM, Hendriks HF, et al. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005; 28:719.</a></li><li><a class="nounderline abstract_t">Reynolds K, Lewis B, Nolen JD, et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003; 289:579.</a></li><li><a class="nounderline abstract_t">Mukamal KJ, Ascherio A, Mittleman MA, et al. Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage. Ann Intern Med 2005; 142:11.</a></li><li><a class="nounderline abstract_t">Elkind MS, Sciacca R, Boden-Albala B, et al. Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke 2006; 37:13.</a></li><li><a class="nounderline abstract_t">Jimenez M, Chiuve SE, Glynn RJ, et al. Alcohol consumption and risk of stroke in women. Stroke 2012; 43:939.</a></li><li><a class="nounderline abstract_t">Sundell L, Salomaa V, Vartiainen E, et al. Increased stroke risk is related to a binge-drinking habit. Stroke 2008; 39:3179.</a></li><li><a class="nounderline abstract_t">Djoussé L, Levy D, Murabito JM, et al. Alcohol consumption and risk of intermittent claudication in the Framingham Heart Study. Circulation 2000; 102:3092.</a></li><li><a class="nounderline abstract_t">López-Laguna N, Martínez-González MA, Toledo E, et al. Risk of peripheral artery disease according to a healthy lifestyle score: The PREDIMED study. Atherosclerosis 2018; 275:133.</a></li><li><a class="nounderline abstract_t">Kodama S, Saito K, Tanaka S, et al. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2011; 57:427.</a></li><li><a class="nounderline abstract_t">Qiao Y, Shi R, Hou B, et al. Impact of Alcohol Consumption on Substrate Remodeling and Ablation Outcome of Paroxysmal Atrial Fibrillation. J Am Heart Assoc 2015; 4.</a></li><li><a class="nounderline abstract_t">Wannamethee SG, Shaper AG. Taking up regular drinking in middle age: effect on major coronary heart disease events and mortality. Heart 2002; 87:32.</a></li><li><a class="nounderline abstract_t">Freiberg MS, Samet JH. Alcohol and coronary heart disease: the answer awaits a randomized controlled trial. Circulation 2005; 112:1379.</a></li><li><a class="nounderline abstract_t">Jackson R, Broad J, Connor J, Wells S. Alcohol and ischaemic heart disease: probably no free lunch. Lancet 2005; 366:1911.</a></li><li><a class="nounderline abstract_t">Ellison RC. Balancing the risks and benefits of moderate drinking. Ann N Y Acad Sci 2002; 957:1.</a></li><li><a class="nounderline abstract_t">Goldberg IJ, Mosca L, Piano MR, et al. AHA Science Advisory: Wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation 2001; 103:472.</a></li><li class="breakAll">http://pubs.niaaa.nih.gov/publications/aa45.htm (Accessed on October 10, 2011).</li><li class="breakAll">Alcohol Guidelines Review – Report from the Guidelines development group to the UK Chief Medical Officers (Accessed on August 06, 2018).</li></ol></div><div id="topicVersionRevision">Topic 2784 Version 53.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : https://www.dietaryguidelines.gov/sites/default/files/2020-12/Dietary_Guidelines_for_Americans_2020-2025.pdf.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30146330" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17846344" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : To drink or not to drink? That is the question.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16340459" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A drink is a drink? Variation in the amount of alcohol contained in beer, wine and spirits drinks in a US methodological sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16340459" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A drink is a drink? Variation in the amount of alcohol contained in beer, wine and spirits drinks in a US methodological sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16340459" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A drink is a drink? Variation in the amount of alcohol contained in beer, wine and spirits drinks in a US methodological sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17825708" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Alcohol and cardiovascular health: the razor-sharp double-edged sword.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16365205" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Importance of pattern of alcohol consumption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24928682" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1351198" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Wine, alcohol, platelets, and the French paradox for coronary heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20391297" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28993373" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Wine and Cardiovascular Health: A Comprehensive Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15710709" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Wine drinking is associated with increased heart rate variability in women with coronary heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15821175" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Autonomic function, omega-3, and cardiovascular risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12519921" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7767150" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Mortality associated with moderate intakes of wine, beer, or spirits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12070110" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Meta-analysis of wine and beer consumption in relation to vascular risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8605457" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19597054" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29676281" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17204515" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Alcohol consumption and breast cancer risk in the Women's Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27459455" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Key Findings on Alcohol Consumption and a Variety of Health Outcomes From the Nurses' Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10591709" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343206" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26849558" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26966281" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The High-Density Lipoprotein Puzzle: Why Classic Epidemiology, Genetic Epidemiology, and Clinical Trials Conflict?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27575649" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Mendelian randomization analysis in three Japanese populations supports a causal role of alcohol consumption in lowering low-density lipid cholesterol levels and particle numbers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26673122" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : New Insights into the High-Density Lipoprotein Dilemma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20392892" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Red wine consumption improves in vitro migration of endothelial progenitor cells in young, healthy individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19065049" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18587418" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15522927" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17440017" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Alcohol consumption and lipoprotein subclasses in older adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11889193" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Glucose tolerance during moderate alcohol intake: insights on insulin action from glucose/lactate dynamics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14652640" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11137839" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Acute and delayed antithrombotic effects of alcohol in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11560851" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12430575" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Regular alcohol intake and fibrinolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12551869" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Alcohol consumption and plasma concentration of C-reactive protein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14769682" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16864759" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Impact of inflammation on the relationship among alcohol consumption, mortality, and cardiac events: the health, aging, and body composition study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9624721" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Alcohol consumption and mortality. I. Characteristics of drinking groups.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15831343" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31978218" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Trends in alcohol consumption in relation to cause-specific and all-cause mortality in the United States: a report from the NHANES linked to the US mortality registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343207" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28818200" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16420195" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28331015" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31847661" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Evidence for a Direct Harmful Effect of Alcohol on Myocardial Health: A Large Cross-Sectional Study of Consumption Patterns and Cardiovascular Disease Risk Biomarkers From Northwest Russia, 2015 to 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20338493" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25948664" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Higher usual alcohol consumption was associated with a lower 41-y mortality risk from coronary artery disease in men independent of genetic and common environmental factors: the prospective NHLBI Twin Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26997174" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Do "Moderate" Drinkers Have Reduced Mortality Risk? A Systematic Review and Meta-Analysis of Alcohol Consumption and All-Cause Mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1467026" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Alcohol and sudden cardiac death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18328303" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Adopting moderate alcohol consumption in middle age: subsequent cardiovascular events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25670624" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20338495" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22453658" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16365208" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Binge drinking and mortality after acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20351238" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26365927" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Alcohol consumption is associated with a lower incidence of acute myocardial infarction: results from a large prospective population-based study in Norway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19933099" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20142394" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21098615" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15477381" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Relationship of alcohol drinking pattern to risk of hypertension: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16585405" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Alcohol and hypertension: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23492672" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Exploring causal associations between alcohol and coronary heart disease risk factors: findings from a Mendelian randomization study in the Copenhagen General Population Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32609894" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Effect of alcohol on blood pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29253389" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17200217" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Alcohol consumption and risk for coronary heart disease among men with hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25091872" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Association between alcohol consumption and risk of cardiovascular disease and all-cause mortality in patients with hypertension: a meta-analysis of prospective cohort studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16843180" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17130341" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Alcohol consumption and risk of heart failure in the Physicians' Health Study I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11827493" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10841221" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10920060" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Alcohol consumption and risk of coronary heart disease by diabetes status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10920059" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11738282" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15735217" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12578491" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Alcohol consumption and risk of stroke: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15630105" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16306464" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22403048" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Alcohol consumption and risk of stroke in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18832741" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Increased stroke risk is related to a binge-drinking habit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11120700" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Alcohol consumption and risk of intermittent claudication in the Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29902701" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Risk of peripheral artery disease according to a healthy lifestyle score: The PREDIMED study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21251583" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Alcohol consumption and risk of atrial fibrillation: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26553213" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Impact of Alcohol Consumption on Substrate Remodeling and Ablation Outcome of Paroxysmal Atrial Fibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11751661" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Taking up regular drinking in middle age: effect on major coronary heart disease events and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16145011" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Alcohol and coronary heart disease: the answer awaits a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16325685" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Alcohol and ischaemic heart disease: probably no free lunch.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12074956" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Balancing the risks and benefits of moderate drinking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11157703" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : AHA Science Advisory: Wine and your heart: a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
